Kate Fallon
banner
katefallon.bsky.social
Kate Fallon
@katefallon.bsky.social
• MD/PhD Candidate | Ervasti & Lowe Labs
• University of Minnesota MSTP
• Interested in muscle, physiology, & genetics

https://scholar.google.com/citations?user=M9ahMIAAAAAJ&hl=en&oi=sra

Interesting analysis of the recent goings-on in the DMD therapy world
Sarepta and the Terrible, Horrible, No Good, Very Bad Week
Here’s what we know about Elevidys showdown, what we don’t, and a few thoughts on where all this could land.
winstoncs.substack.com
July 28, 2025 at 5:59 PM
Reposted by Kate Fallon
1. Today the NIH director issued a new directive slashing overhead rates to 15%.

I want to provide some context on what that means and why it matters.

grants.nih.gov/grants/guide...
NOT-OD-25-068: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates
NIH Funding Opportunities and Notices in the NIH Guide for Grants and Contracts: Supplemental Guidance to the 2024 NIH Grants Policy Statement: Indirect Cost Rates NOT-OD-25-068. OD
grants.nih.gov
February 8, 2025 at 12:18 AM
Excited to share new work from the Ervasti Lab, published last week in JCI, which will inform the foundation of my thesis research. Check it out below! 🐁 💪🏼 #myoblue
JCI - Impaired hydrogen sulfide biosynthesis underlies eccentric contraction-induced force loss in dystrophin-deficient skeletal muscle
www.jci.org
January 20, 2025 at 3:50 AM